摘要
目的探讨依达拉奉联合醒脑静治疗高血压脑出血的临床疗效。方法选取我院高血压脑出血患者69例,随机分为实验组和对照组,实验组39例,对照组30例,对照组给予依达拉奉治疗,实验组在依达拉奉治疗的基础上加用醒脑静治疗,观察两组患者的临床疗效。结果治疗后,两组神经功能缺损评分均有所减少,实验组评分明显低于对照组(P<0.05),实验组有效率为92.31%,对照组有效率为76.67%,实验组疗效明显优于对照组(P<0.05)。结论依达拉奉联合醒脑静治疗高血压脑出血的临床疗效明显优于单用依达拉奉治疗。
Objective To investigate the clinical therapeutic effects of edaravone combined with xingnaojing injection in treatment of patients with hypertensive cerebral hemorrhage. Methods Sixty-nine patients with hypertensive cerebral hemorrhage were randomly divided into the experimental group and the control group. There were 39 patients in experimental group and there were 30 patients in control group. The control group was treated with edaravone and the experimental group was treated with edaravone combined with xingnaojing injection.The therapeutic effects in these two groups were evaluated. Results The scores of nerves afunction of the patients in both groups after treatment were obvously lower than those before threatment and the scores of nerves afunction of the patients in the experimental group were lower than those in the control group（P 〈0.05）. The effective rate of control group was 76.67%. The effective rate of experimental group was 92.31%. The effect of experimental group was significantly higher than that of control group （P 〈0.05）. Conclusion Therapeutic effects of edaravone combined xingnaojing injection in treating patients with acute cerebral hemorrhage are better than only edaravone treatment.
出处
《中国现代医生》
2014年第3期37-38,40,共3页
China Modern Doctor
关键词
依达拉奉
脑醒静
高血压
脑出血
Edaravone
Xingnaojing injection
Hypertensive
Cerebral hemorrhage
